Maternal and perinatal factors associated with cord blood thyroid-stimulating hormone levels: a cross-sectional study
Annals of Pediatric Endocrinology & Metabolism · 2026-10-31 · 31 (5) · 310-318
DOI: 10.6065/apem.2550418.209 ↗Abstract
Purpose: Congenital hypothyroidism (CH) is the most common preventable cause of intellectual disability in children. Umbilical cord blood thyroid-stimulating hormone (TSH) is used for neonatal screening, but maternal and perinatal influences on cord blood TSH remain incompletely understood. This study aimed to identify maternal and perinatal factors associated with cord blood TSH levels.Methods: A descriptive, cross-sectional study was conducted among 1,088 consecutive live births at a tertiary hospital in South India (January–December 2022). Cord blood samples were analyzed for TSH using an electrochemiluminescence immunoassay. Maternal and neonatal characteristics were recorded, and associations with cord blood TSH were assessed. Neonates with cord blood TSH >20 μIU/mL were recalled for confirmatory serum thyroid function testing.Results: The median cord blood TSH was 7.22 μIU/mL, with an interquartile range of 5.39–10.28. Elevated cord blood TSH (>20 μIU/mL) was found in 5.9% of neonates. In unadjusted analyses, higher TSH levels were associated with primiparity, gestational diabetes, gestational hypertension, vaginal delivery, assisted delivery, and lower Apgar scores (P
EUVIMED